Pheon Therapeutics raised $120m in a Series B financing led by TCGX with participation from BVF Partners, Lightspeed, and Perceptive Advisors.
Amount Raised
$120 Million
Round Type
Series B
LondonBiotechnologyHealth CareTherapeuticsInvestors
Description
Pheon Therapeutics completed a $120m Series B financing to fund the development of its pipeline of differentiated ADCs. The financing was led by TCGX with participation from other new investors BVF Partners, Lightspeed and Perceptive Advisors, alongside existing investors Atlas Venture, Brandon Capital, Forbion, and Research Corporation Technologies. The new financing will be used to further advance Pheon’s differentiated ADC pipeline through clinical proof of concept and to expand the company's suite of in-house technology platforms.
Quick answer
Pheon Therapeutics raised $120 Million in a Series B round, dated May 21, 2024. Investors: Research Corporation Technologies, Forbion, Brandon Capital, Atlas Venture, Perceptive Advisors, Lightspeed, BVF Partners and Tcgx. Pheon Therapeutics is based in London, England, United Kingdom.
- How much did Pheon Therapeutics raise?
- Pheon Therapeutics raised $120 Million in a Series B round on May 21, 2024.
- Who invested in Pheon Therapeutics?
- Research Corporation Technologies, Forbion, Brandon Capital, Atlas Venture, Perceptive Advisors, Lightspeed, BVF Partners and Tcgx are named as investors in this round.
- What does Pheon Therapeutics do?
- Pheon Therapeutics is an Antibody Drug Conjugate (ADC) specialist developing a pipeline of monotherapies for novel targets and/or with novel payloads.
- Where is Pheon Therapeutics based and how big is it?
- Pheon Therapeutics is based in London, England, United Kingdom.
- Who are the decision-makers at Pheon Therapeutics?
- Fundz holds 1 contact at Pheon Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Pheon Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Virpax Pharmaceuticals raised $2.5M on July 5, 2024.
- NGM Bio raised $73M on July 5, 2024.
- Beacon Therapeutics raised $170M (Series B) on July 3, 2024.
- Cartesian Therapeutics, Inc. raised $130M on July 2, 2024.
- N-Power Medicine raised $72M (Series B) on July 1, 2024.
- Scorpion Therapeutics raised $126M on July 1, 2024.
Who to call at Pheon Therapeutics, and when
A new round usually means Pheon Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pheon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pheon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pheon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pheon Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPheon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.